US Patent Issued to LEGEND BIOTECH USA on July 8 for "Chimeric antigen receptors targeting BCMA and methods of use thereof" (Chinese, Canadian Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,638, issued on July 8, was assigned to LEGEND BIOTECH USA INC. (Wilmington, Del.).

"Chimeric antigen receptors targeting BCMA and methods of use thereof" was invented by Xiaohu Fan (Edmonton, Canada), Qiuchuan Zhuang (Jiangsu, China), Pingyan Wang (Anhui, China), Lin Wang (Jiangsu, China), Lei Yang (Anhui, China), Jiaying Hao (Jiangsu, China), Dan Zhao (Jiangsu, China) and Xian He (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides single-domain antibodies targeting BCMA, and chimeric antigen receptors (such as monovalent CAR, and multivalent CAR including bi-epitope CAR) comprising one or more anti-BCMA si...